GI Innovation, Inc. (KOSDAQ:358570)
South Korea · Delayed Price · Currency is KRW 8,770.00
-620.00 (-6.60%)
Sep 22, 2026, 3:30 PM KST
GI Innovation Market Cap
GI Innovation has a market cap or net worth of 605.81 billion as of September 22, 2026. Its market cap has decreased by -50.13% in one year.
Market Cap
605.81B
Enterprise Value
568.49B
Revenue
5.50B
Ranking
n/a
PE Ratio
n/a
Stock Price
8,770.00
ChartMarket Cap Chart
Since March 30, 2023, GI Innovation's market cap has increased from 445.59B to 605.81B, an increase of 35.96%. That is a compound annual growth rate of 9.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 605.81B | -46.21% |
| Dec 30, 2025 | 1.13T | 187.90% |
| Dec 30, 2024 | 391.21B | -26.45% |
| Dec 28, 2023 | 531.89B | 19.37% |
| Mar 30, 2023 | 445.59B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Orum Therapeutics | 812.31B |
| Pharmicell | 751.85B |
| Chabiotech | 740.02B |
| Komipharm International | 711.84B |
| Onconic Therapeutics | 674.76B |
| Hyundai Bioscience | 656.22B |
| Medy-Tox | 434.64B |
| GC Corp. | 433.96B |